108 related articles for article (PubMed ID: 29940761)
1. Overexpression of EPS8L3 promotes cell proliferation by inhibiting the transactivity of FOXO1 in HCC.
Zeng CX; Tang LY; Xie CY; Li FX; Zhao JY; Jiang N; Tong Z; Fu SB; Wen FJ; Feng WS
Neoplasma; 2018 Sep; 65(5):701-707. PubMed ID: 29940761
[TBL] [Abstract][Full Text] [Related]
2. TCF19 enhances cell proliferation in hepatocellular carcinoma by activating the ATK/FOXO1 signaling pathway.
Zeng CX; Fu SB; Feng WS; Zhao JY; Li FX; Gao P
Neoplasma; 2019 Jan; 66(1):46-53. PubMed ID: 30509085
[TBL] [Abstract][Full Text] [Related]
3. The oncoprotein HBXIP suppresses gluconeogenesis through modulating PCK1 to enhance the growth of hepatoma cells.
Shi H; Fang R; Li Y; Li L; Zhang W; Wang H; Chen F; Zhang S; Zhang X; Ye L
Cancer Lett; 2016 Nov; 382(2):147-156. PubMed ID: 27609066
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of EPS8L3 suppresses liver cancer progression and enhances efficacy of sorafenib treatment.
Chen B; Pan Y; Xu X; Wu F; Zheng X; Chen SY; Zhao YT; Huang Z; Cheng SH; Liu JX; Wang WH; Li YX
Biomed Pharmacother; 2020 Aug; 128():110284. PubMed ID: 32480224
[TBL] [Abstract][Full Text] [Related]
5. Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1.
Kan H; Huang Y; Li X; Liu D; Chen J; Shu M
Oncotarget; 2016 Mar; 7(12):14336-49. PubMed ID: 26893361
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of EPS8L3 is associated with tumorigenesis and poor prognosis in patients with liver cancer.
Li P; Hu T; Wang H; Tang Y; Ma Y; Wang X; Xu Y; Chen G
Mol Med Rep; 2019 Sep; 20(3):2493-2499. PubMed ID: 31322213
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-145 suppresses hepatocellular carcinoma by targeting IRS1 and its downstream Akt signaling.
Wang Y; Hu C; Cheng J; Chen B; Ke Q; Lv Z; Wu J; Zhou Y
Biochem Biophys Res Commun; 2014 Apr; 446(4):1255-60. PubMed ID: 24690171
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-1269 promotes proliferation in human hepatocellular carcinoma via downregulation of FOXO1.
Yang XW; Shen GZ; Cao LQ; Jiang XF; Peng HP; Shen G; Chen D; Xue P
BMC Cancer; 2014 Dec; 14():909. PubMed ID: 25472505
[TBL] [Abstract][Full Text] [Related]
9. YAP1-activated ZNF131 promotes hepatocellular carcinoma cell proliferation through transcriptional regulation of PAIP1.
Yin G; Jia S; Zhang Y; Xian Y; Guo Y; Liu Q
Arch Biochem Biophys; 2024 Apr; 754():109921. PubMed ID: 38341068
[TBL] [Abstract][Full Text] [Related]
10. EPS8L3 promotes hepatocellular carcinoma proliferation and metastasis by modulating EGFR dimerization and internalization.
Xuan Z; Zhao L; Li Z; Song W; Chen J; Chen J; Chen H; Song G; Jin C; Zhou M; Xie H; Zheng S; Song P
Am J Cancer Res; 2020; 10(1):60-77. PubMed ID: 32064153
[TBL] [Abstract][Full Text] [Related]
11. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
12. The RNA-binding protein Sam68 regulates tumor cell viability and hepatic carcinogenesis by inhibiting the transcriptional activity of FOXOs.
Zhang T; Wan C; Shi W; Xu J; Fan H; Zhang S; Lin Z; Ni R; Zhang X
J Mol Histol; 2015 Dec; 46(6):485-97. PubMed ID: 26438629
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of microRNA‑300 induces the proliferation of liver cancer by downregulating transcription factor FOXO1.
Chang Y; Zhou C; Fan L; Qiu G; Wang G; Wei G; Chang X; Li X
Oncol Rep; 2018 Dec; 40(6):3561-3572. PubMed ID: 30272296
[TBL] [Abstract][Full Text] [Related]
14. Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma.
Wang J; Xia C; Pu M; Dai B; Yang X; Shang R; Yang Z; Zhang R; Tao K; Dou K
Oncol Rep; 2018 Oct; 40(4):1875-1884. PubMed ID: 30015982
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-3127 promotes cell proliferation and tumorigenicity in hepatocellular carcinoma by disrupting of PI3K/AKT negative regulation.
Jiang J; Zhang Y; Guo Y; Yu C; Chen M; Li Z; Tian S; Sun C
Oncotarget; 2015 Mar; 6(8):6359-72. PubMed ID: 25849943
[TBL] [Abstract][Full Text] [Related]
16. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
Qiu FN; Huang Y; Chen DY; Li F; Wu YA; Wu WB; Huang XL
World J Gastroenterol; 2016 Apr; 22(16):4226-37. PubMed ID: 27122673
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Rab5a promotes hepatocellular carcinoma cell proliferation and invasion via FAK signaling pathway.
Geng D; Zhao W; Feng Y; Liu J
Tumour Biol; 2016 Mar; 37(3):3341-7. PubMed ID: 26443539
[TBL] [Abstract][Full Text] [Related]
18. Suppression by heat shock protein 20 of hepatocellular carcinoma cell proliferation via inhibition of the mitogen-activated protein kinases and AKT pathways.
Matsushima-Nishiwaki R; Adachi S; Yoshioka T; Yasuda E; Yamagishi Y; Matsuura J; Muko M; Iwamura R; Noda T; Toyoda H; Kaneoka Y; Okano Y; Kumada T; Kozawa O
J Cell Biochem; 2011 Nov; 112(11):3430-9. PubMed ID: 21769911
[TBL] [Abstract][Full Text] [Related]
19. TRIP6 promotes cell proliferation in hepatocellular carcinoma via suppression of FOXO3a.
Zhao W; Dai Y; Dai T; Xie T; Su X; Li J; Zhou X; Meng K; Zhao X
Biochem Biophys Res Commun; 2017 Dec; 494(3-4):594-601. PubMed ID: 29080747
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-155 promotes tumor growth of human hepatocellular carcinoma by targeting ARID2.
Zhang L; Wang W; Li X; He S; Yao J; Wang X; Zhang D; Sun X
Int J Oncol; 2016 Jun; 48(6):2425-34. PubMed ID: 27035278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]